Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Device: communication system P300 Speller
- Registration Number
- NCT01897818
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
ALS is a severe progressive neurodegenerative disease characterized by degeneration motor neurons leading to death in 3 to 5 years. Gradually in time, the patient deprived of all motor skills as well as the possibility of communication written and oral developing a state close Locked In Syndrome (LIS). The main objective is to establish the feasibility of brain-computer interface using the pathological condition, with dependent disabled subjects as a means of communication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- age >= 18
- have a diagnosis of ALS suspected, possible, probable with EMG
- be able to follow the study process and to comply with the schedule of visits upon entry into the study
- understand the purpose of the study
- expressing P300 wave in the conditions of the study
- have a mental illness or clinical dementia defined clinically significant may hinder the patient's ability to follow the procedures of the study
- have a significant history of photosensitive epilepsy
- have a history of allergy to the gel used for the electrodes
- Major protected by law (guardianship, curators)
- have uncorrectable visual disorders
- not being able to maintain a sitting position and focus on a computer screen for more than 30 min.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ALS patients communication system P300 Speller -
- Primary Outcome Measures
Name Time Method the full achievement of "copy spelling" and "free spelling" tests session 1 14 days after inclusion the full achievement of "copy spelling" and "free spelling" tests session 2 28 days after inclusion
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital de l'Archet I
🇫🇷Nice, France